Amicus brief of over 300 reproductive health researchers supports mifepristone's safety and effectiveness
Perspectives on Sexual and Reproductive Health · 2024
DOI: 10.1111/psrh.12282 ↗Kurz gefasst
Fachartikel in der Zeitschrift Perspectives on Sexual and Reproductive Health, 2024. Verfasst von Amanda Barrow und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center on Reproductive Health, Law, and Policy, University of California Los Angeles, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Mifepristone, United States Food and Drug Administration, Abortion, Induced, Abortifacient Agents, Steroidal. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
On January 30, 2024, over 300 researchers filed an amicus brief in FDA v. Alliance for Hippocratic Medicine , a United States (US) Supreme Court case concerning the regulatory status of mifepristone, one of two drugs used in medication abortion. In this Comment we summarize the legal challenge, responses from the FDA and drug manufacturer to these challenges, oral arguments presented before the Court, and the implications of the Court's decision on access to mifepristone in the US. We also summarize the content of the accompanying amicus brief.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center on Reproductive Health, Law, and Policy, University of California Los Angeles, Los Angeles, California, USA.
- Department of Obstetrics, Gynecology, & Reproductive Sciences, University of California San Francisco, Advancing New Standards in Reproductive Health, Oakland, California, USA.
Zitieren
APA
Barrow, A., Cohen, C., Serpico, J., Goodman, M., Grossman, D., Raifman, S., & Upadhyay, U. (2024). Amicus brief of over 300 reproductive health researchers supports mifepristone's safety and effectiveness. Perspectives on Sexual and Reproductive Health. https://doi.org/10.1111/psrh.12282
Vancouver
Barrow A, Cohen C, Serpico J, Goodman M, Grossman D, Raifman S, et al. Amicus brief of over 300 reproductive health researchers supports mifepristone's safety and effectiveness. Perspectives on Sexual and Reproductive Health. 2024. doi:10.1111/psrh.12282
BibTeX
@article{Barrow2024,
author = {Barrow, Amanda and Cohen, Cathren and Serpico, Jaclyn and Goodman, Melissa and Grossman, Daniel and Raifman, Sarah and Upadhyay, Ushma},
title = {Amicus brief of over 300 reproductive health researchers supports mifepristone's safety and effectiveness},
journal = {Perspectives on Sexual and Reproductive Health},
year = {2024},
doi = {10.1111/psrh.12282}
}
EUVIMED